Staying on Track: Navigating Regulatory Scrutiny in Private Equity Health Care Transactions
With proposed oversight mechanisms on the rise, members of Congress, State Attorneys General and other regulators have been scrutinizing private equity-backed health care providers. Join us for a webinar on August 15 focusing on the increasing regulatory scrutiny on private equity-backed health care providers. During this webinar, Hall Render attorneys Kelci Laster, Abby Kaericher, Colleen Powers and Rubin Pusha will outline proposed rules and recent oversight trends, and discuss the impact on private equity-backed health care M&A activity.
Our panelists will delve into the following key topics:
- The Role of “Friendly PC” and MSO Models: Understanding the structure and functionality of professional corporation (PC) and Management Services Organization (MSO) models in the context of private equity investments.
- FTC and State Oversight for Roll-Up Models: Exploring the Federal Trade Commission (FTC) and state-level regulatory oversight for roll-up strategies, where smaller practices are consolidated into larger entities.
- Heightened Congressional Attention: Analyzing the implications of federal legislative proposals, such as the “Corporate Crimes Against Health Care Act”, on corporate accountability and compliance for health care providers.
- Current Transaction Trends for PE-Backed Providers: Identifying emerging trends and patterns in transactions involving private equity-backed health care entities.
Potential Impact for Health Care Entities Transacting with PE: Evaluating the broader implications for health care providers engaging in transactions with private equity firms, including due diligence and regulatory compliance considerations.
